Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Endometriosis affects an estimated 1 in 10 women in the reproductive age group of 15-49 years.
Endometriosis Drugs market report explains the definition, types, applications, major countries, and major players of the Endometriosis Drugs market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Evotec AG
AstraZeneca
ValiRx
ObsEva
Roivant Sciences GmbH
Repros Therapeutics
Kissei Pharmaceutical
Debiopharm Group
AbbVie
Takeda Pharmaceutical Company Limited
Astellas Pharma
Neurocrine Biosciences
Pfizer
By Type:
Hormonal Therapy
Add-back Medication
Progestogens
Chinese Herbs
By End-User:
Hospitals
Clinics
Research Institutes
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Endometriosis Drugs Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Endometriosis Drugs Outlook to 2028- Original Forecasts
-
2.2 Endometriosis Drugs Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Endometriosis Drugs Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Endometriosis Drugs Market- Recent Developments
-
6.1 Endometriosis Drugs Market News and Developments
-
6.2 Endometriosis Drugs Market Deals Landscape
7 Endometriosis Drugs Raw Materials and Cost Structure Analysis
-
7.1 Endometriosis Drugs Key Raw Materials
-
7.2 Endometriosis Drugs Price Trend of Key Raw Materials
-
7.3 Endometriosis Drugs Key Suppliers of Raw Materials
-
7.4 Endometriosis Drugs Market Concentration Rate of Raw Materials
-
7.5 Endometriosis Drugs Cost Structure Analysis
-
7.5.1 Endometriosis Drugs Raw Materials Analysis
-
7.5.2 Endometriosis Drugs Labor Cost Analysis
-
7.5.3 Endometriosis Drugs Manufacturing Expenses Analysis
8 Global Endometriosis Drugs Import and Export Analysis (Top 10 Countries)
-
8.1 Global Endometriosis Drugs Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Endometriosis Drugs Export by Region (Top 10 Countries) (2017-2028)
9 Global Endometriosis Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Endometriosis Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Hormonal Therapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Add-back Medication Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Progestogens Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Chinese Herbs Consumption and Growth Rate (2017-2022)
-
9.2 Global Endometriosis Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Research Institutes Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Endometriosis Drugs Market Analysis and Outlook till 2022
-
10.1 Global Endometriosis Drugs Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Endometriosis Drugs Consumption (2017-2022)
-
10.2.2 Canada Endometriosis Drugs Consumption (2017-2022)
-
10.2.3 Mexico Endometriosis Drugs Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Endometriosis Drugs Consumption (2017-2022)
-
10.3.2 UK Endometriosis Drugs Consumption (2017-2022)
-
10.3.3 Spain Endometriosis Drugs Consumption (2017-2022)
-
10.3.4 Belgium Endometriosis Drugs Consumption (2017-2022)
-
10.3.5 France Endometriosis Drugs Consumption (2017-2022)
-
10.3.6 Italy Endometriosis Drugs Consumption (2017-2022)
-
10.3.7 Denmark Endometriosis Drugs Consumption (2017-2022)
-
10.3.8 Finland Endometriosis Drugs Consumption (2017-2022)
-
10.3.9 Norway Endometriosis Drugs Consumption (2017-2022)
-
10.3.10 Sweden Endometriosis Drugs Consumption (2017-2022)
-
10.3.11 Poland Endometriosis Drugs Consumption (2017-2022)
-
10.3.12 Russia Endometriosis Drugs Consumption (2017-2022)
-
10.3.13 Turkey Endometriosis Drugs Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Endometriosis Drugs Consumption (2017-2022)
-
10.4.2 Japan Endometriosis Drugs Consumption (2017-2022)
-
10.4.3 India Endometriosis Drugs Consumption (2017-2022)
-
10.4.4 South Korea Endometriosis Drugs Consumption (2017-2022)
-
10.4.5 Pakistan Endometriosis Drugs Consumption (2017-2022)
-
10.4.6 Bangladesh Endometriosis Drugs Consumption (2017-2022)
-
10.4.7 Indonesia Endometriosis Drugs Consumption (2017-2022)
-
10.4.8 Thailand Endometriosis Drugs Consumption (2017-2022)
-
10.4.9 Singapore Endometriosis Drugs Consumption (2017-2022)
-
10.4.10 Malaysia Endometriosis Drugs Consumption (2017-2022)
-
10.4.11 Philippines Endometriosis Drugs Consumption (2017-2022)
-
10.4.12 Vietnam Endometriosis Drugs Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Endometriosis Drugs Consumption (2017-2022)
-
10.5.2 Colombia Endometriosis Drugs Consumption (2017-2022)
-
10.5.3 Chile Endometriosis Drugs Consumption (2017-2022)
-
10.5.4 Argentina Endometriosis Drugs Consumption (2017-2022)
-
10.5.5 Venezuela Endometriosis Drugs Consumption (2017-2022)
-
10.5.6 Peru Endometriosis Drugs Consumption (2017-2022)
-
10.5.7 Puerto Rico Endometriosis Drugs Consumption (2017-2022)
-
10.5.8 Ecuador Endometriosis Drugs Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Endometriosis Drugs Consumption (2017-2022)
-
10.6.2 Kuwait Endometriosis Drugs Consumption (2017-2022)
-
10.6.3 Oman Endometriosis Drugs Consumption (2017-2022)
-
10.6.4 Qatar Endometriosis Drugs Consumption (2017-2022)
-
10.6.5 Saudi Arabia Endometriosis Drugs Consumption (2017-2022)
-
10.6.6 United Arab Emirates Endometriosis Drugs Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Endometriosis Drugs Consumption (2017-2022)
-
10.7.2 South Africa Endometriosis Drugs Consumption (2017-2022)
-
10.7.3 Egypt Endometriosis Drugs Consumption (2017-2022)
-
10.7.4 Algeria Endometriosis Drugs Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Endometriosis Drugs Consumption (2017-2022)
-
10.8.2 New Zealand Endometriosis Drugs Consumption (2017-2022)
11 Global Endometriosis Drugs Competitive Analysis
-
11.1 Evotec AG
-
11.1.1 Evotec AG Company Details
-
11.1.2 Evotec AG Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Evotec AG Endometriosis Drugs Main Business and Markets Served
-
11.1.4 Evotec AG Endometriosis Drugs Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 AstraZeneca
-
11.2.1 AstraZeneca Company Details
-
11.2.2 AstraZeneca Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 AstraZeneca Endometriosis Drugs Main Business and Markets Served
-
11.2.4 AstraZeneca Endometriosis Drugs Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 ValiRx
-
11.3.1 ValiRx Company Details
-
11.3.2 ValiRx Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 ValiRx Endometriosis Drugs Main Business and Markets Served
-
11.3.4 ValiRx Endometriosis Drugs Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 ObsEva
-
11.4.1 ObsEva Company Details
-
11.4.2 ObsEva Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 ObsEva Endometriosis Drugs Main Business and Markets Served
-
11.4.4 ObsEva Endometriosis Drugs Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Roivant Sciences GmbH
-
11.5.1 Roivant Sciences GmbH Company Details
-
11.5.2 Roivant Sciences GmbH Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Roivant Sciences GmbH Endometriosis Drugs Main Business and Markets Served
-
11.5.4 Roivant Sciences GmbH Endometriosis Drugs Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Repros Therapeutics
-
11.6.1 Repros Therapeutics Company Details
-
11.6.2 Repros Therapeutics Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Repros Therapeutics Endometriosis Drugs Main Business and Markets Served
-
11.6.4 Repros Therapeutics Endometriosis Drugs Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Kissei Pharmaceutical
-
11.7.1 Kissei Pharmaceutical Company Details
-
11.7.2 Kissei Pharmaceutical Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Kissei Pharmaceutical Endometriosis Drugs Main Business and Markets Served
-
11.7.4 Kissei Pharmaceutical Endometriosis Drugs Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Debiopharm Group
-
11.8.1 Debiopharm Group Company Details
-
11.8.2 Debiopharm Group Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Debiopharm Group Endometriosis Drugs Main Business and Markets Served
-
11.8.4 Debiopharm Group Endometriosis Drugs Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 AbbVie
-
11.9.1 AbbVie Company Details
-
11.9.2 AbbVie Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 AbbVie Endometriosis Drugs Main Business and Markets Served
-
11.9.4 AbbVie Endometriosis Drugs Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Takeda Pharmaceutical Company Limited
-
11.10.1 Takeda Pharmaceutical Company Limited Company Details
-
11.10.2 Takeda Pharmaceutical Company Limited Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Takeda Pharmaceutical Company Limited Endometriosis Drugs Main Business and Markets Served
-
11.10.4 Takeda Pharmaceutical Company Limited Endometriosis Drugs Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Astellas Pharma
-
11.11.1 Astellas Pharma Company Details
-
11.11.2 Astellas Pharma Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Astellas Pharma Endometriosis Drugs Main Business and Markets Served
-
11.11.4 Astellas Pharma Endometriosis Drugs Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Neurocrine Biosciences
-
11.12.1 Neurocrine Biosciences Company Details
-
11.12.2 Neurocrine Biosciences Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Neurocrine Biosciences Endometriosis Drugs Main Business and Markets Served
-
11.12.4 Neurocrine Biosciences Endometriosis Drugs Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Pfizer
-
11.13.1 Pfizer Company Details
-
11.13.2 Pfizer Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Pfizer Endometriosis Drugs Main Business and Markets Served
-
11.13.4 Pfizer Endometriosis Drugs Product Portfolio
-
11.13.5 Recent Research and Development Strategies
12 Global Endometriosis Drugs Market Outlook by Types and Applications to 2028
-
12.1 Global Endometriosis Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Hormonal Therapy Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Add-back Medication Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Progestogens Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Chinese Herbs Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Endometriosis Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Endometriosis Drugs Market Analysis and Outlook to 2028
-
13.1 Global Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.2.2 Canada Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.2.3 Mexico Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.3.2 UK Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.3.3 Spain Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.3.4 Belgium Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.3.5 France Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.3.6 Italy Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.3.7 Denmark Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.3.8 Finland Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.3.9 Norway Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.3.10 Sweden Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.3.11 Poland Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.3.12 Russia Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.3.13 Turkey Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.4.2 Japan Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.4.3 India Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.4.4 South Korea Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.4.8 Thailand Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.4.9 Singapore Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.4.11 Philippines Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.5.2 Colombia Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.5.3 Chile Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.5.4 Argentina Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.5.6 Peru Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.6.3 Oman Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.6.4 Qatar Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.7.2 South Africa Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.7.3 Egypt Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.7.4 Algeria Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Endometriosis Drugs Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Endometriosis Drugs Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Endometriosis Drugs
-
Figure of Endometriosis Drugs Picture
-
Table Global Endometriosis Drugs Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Endometriosis Drugs Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Hormonal Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Add-back Medication Consumption and Growth Rate (2017-2022)
-
Figure Global Progestogens Consumption and Growth Rate (2017-2022)
-
Figure Global Chinese Herbs Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Research Institutes Consumption and Growth Rate (2017-2022)
-
Figure Global Endometriosis Drugs Consumption by Country (2017-2022)
-
Table North America Endometriosis Drugs Consumption by Country (2017-2022)
-
Figure United States Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Canada Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Mexico Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Endometriosis Drugs Consumption by Country (2017-2022)
-
Figure Germany Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure UK Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Spain Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Belgium Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure France Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Italy Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Denmark Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Finland Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Norway Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Sweden Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Poland Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Russia Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Turkey Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Table APAC Endometriosis Drugs Consumption by Country (2017-2022)
-
Figure China Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Thailand Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Singapore Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Philippines Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Table South America Endometriosis Drugs Consumption by Country (2017-2022)
-
Figure Brazil Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Colombia Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Chile Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Argentina Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Peru Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Table GCC Endometriosis Drugs Consumption by Country (2017-2022)
-
Figure Bahrain Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Oman Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Qatar Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Table Africa Endometriosis Drugs Consumption by Country (2017-2022)
-
Figure Nigeria Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Africa Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Egypt Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Algeria Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Table Oceania Endometriosis Drugs Consumption by Country (2017-2022)
-
Figure Australia Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Endometriosis Drugs Consumption and Growth Rate (2017-2022)
-
Table Evotec AG Company Details
-
Table Evotec AG Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Evotec AG Endometriosis Drugs Main Business and Markets Served
-
Table Evotec AG Endometriosis Drugs Product Portfolio
-
Table AstraZeneca Company Details
-
Table AstraZeneca Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Endometriosis Drugs Main Business and Markets Served
-
Table AstraZeneca Endometriosis Drugs Product Portfolio
-
Table ValiRx Company Details
-
Table ValiRx Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table ValiRx Endometriosis Drugs Main Business and Markets Served
-
Table ValiRx Endometriosis Drugs Product Portfolio
-
Table ObsEva Company Details
-
Table ObsEva Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table ObsEva Endometriosis Drugs Main Business and Markets Served
-
Table ObsEva Endometriosis Drugs Product Portfolio
-
Table Roivant Sciences GmbH Company Details
-
Table Roivant Sciences GmbH Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roivant Sciences GmbH Endometriosis Drugs Main Business and Markets Served
-
Table Roivant Sciences GmbH Endometriosis Drugs Product Portfolio
-
Table Repros Therapeutics Company Details
-
Table Repros Therapeutics Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Repros Therapeutics Endometriosis Drugs Main Business and Markets Served
-
Table Repros Therapeutics Endometriosis Drugs Product Portfolio
-
Table Kissei Pharmaceutical Company Details
-
Table Kissei Pharmaceutical Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kissei Pharmaceutical Endometriosis Drugs Main Business and Markets Served
-
Table Kissei Pharmaceutical Endometriosis Drugs Product Portfolio
-
Table Debiopharm Group Company Details
-
Table Debiopharm Group Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Debiopharm Group Endometriosis Drugs Main Business and Markets Served
-
Table Debiopharm Group Endometriosis Drugs Product Portfolio
-
Table AbbVie Company Details
-
Table AbbVie Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Endometriosis Drugs Main Business and Markets Served
-
Table AbbVie Endometriosis Drugs Product Portfolio
-
Table Takeda Pharmaceutical Company Limited Company Details
-
Table Takeda Pharmaceutical Company Limited Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Company Limited Endometriosis Drugs Main Business and Markets Served
-
Table Takeda Pharmaceutical Company Limited Endometriosis Drugs Product Portfolio
-
Table Astellas Pharma Company Details
-
Table Astellas Pharma Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Endometriosis Drugs Main Business and Markets Served
-
Table Astellas Pharma Endometriosis Drugs Product Portfolio
-
Table Neurocrine Biosciences Company Details
-
Table Neurocrine Biosciences Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Neurocrine Biosciences Endometriosis Drugs Main Business and Markets Served
-
Table Neurocrine Biosciences Endometriosis Drugs Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Endometriosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Endometriosis Drugs Main Business and Markets Served
-
Table Pfizer Endometriosis Drugs Product Portfolio
-
Figure Global Hormonal Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Add-back Medication Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Progestogens Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chinese Herbs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Endometriosis Drugs Consumption Forecast by Country (2022-2028)
-
Table North America Endometriosis Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Endometriosis Drugs Consumption Forecast by Country (2022-2028)
-
Figure Germany Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Endometriosis Drugs Consumption Forecast by Country (2022-2028)
-
Figure China Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Endometriosis Drugs Consumption Forecast by Country (2022-2028)
-
Figure Brazil Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Endometriosis Drugs Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Endometriosis Drugs Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Endometriosis Drugs Consumption Forecast by Country (2022-2028)
-
Figure Australia Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Endometriosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
